Læknaneminn - 01.10.1987, Síða 12

bral ischemic attacks as a comp-
lication of heart disease: the val-
ue of echocardiography. Acta
Neurol Scand 1986: 74:323-327.
15. Koudstaal P. J., van Gun J.,
Klootwijk A. P. J., van der
Meche F. G. A., Kappelle L. J.
Holter monitoring in patients
with transient and focal ischemic
atacks of the brain. Stroke
1986:17:192-195.
16. Rem J. A., Hachinski V. C.,
Boughner D. R., Barnett H. J.
M. Value of cardiac monitoring
and echocardiography in TIA
and stroke patients. Stroke
1985:16:950-956.
17. Shapiro L. M., Westgate C. J.,
Shine K., Donaldson R. Is cardi-
ac ultrasound mandatory in pat-
ients with transient ischaemic
attacks? Br Med J
1985:291:786-787.
18. Lavin P. Management of hyper-
tension in patients with acute
stroke. Arch Intern Med
1986:146:66-68.
19. Yatsu F. M., Zivin J. Hypertens-
ion in acute ischemic strokes. Not
to treat. Arch Neurol
1985:42:999-1000.
20. Spence J. D., Del Maestro R.F.
Hypertension in acute ischemic
strokes. Treat. Arch Neurol
1985:42:1000-1002.
21. Starkey I., Warlow C., Sherman
D. G., Hart R. G., Easton J. D.
The secondary prevention of
stroke in patients with atrial íibr-
illation. Arch Neurol
1986:43:66-70.
22. Wolf P.A., Abbott R. D., Kann-
el W. B. Atrial fibrillation: a ma-
jor contributor to stroke in the
elderly. The Framingham study.
Arch Intern Med
1987:147:1561-1564.
23. Ritstjórnargrein. Aspirin: what
dose? Lancet 1986:592-593.
24. Hirsh J. The optimal antithrom-
botic dose of aspirin. Arch Intern
Med 1985:1582-1583.
25. The Canadian cooperative study
group. A randomized trial of asp-
irin and sulfinpyrazone in threat-
ened stroke. N Engl J Med
1978:299:53-59.
26. Gent M. Single studies and
overview analyses: is aspirin of
value in cerebral ischemia? Stro-
ke 1987:18:541-544.
27. Grotta J. C., Lemak N. A., Gary
H., Fields W. S., Vital D. Does
platelet antiaggregant therapy
lessen the severity of stroke?
Neurology 1985:35:632-636.
28. Hinds C. J. Prevention and
treatment of brain ischaemia. Br
MedJ 1985:291:758-760.
29. Gisvold S. E., Steen P. A. Drug
therapy in brain ischemia. Br J
Anaesth 1985:57:96-109.
30. Papadopulos-Eleopulos E., Fox
R. A. Effects of dimethyl sulf-
oxide on cerebral arteries. Stroke
1987:18:812.
31. Rappaport Z. H., Young W.,
Flamm E. S. Regional brain
calcium changes in the rat midd-
le cerebral artery occlusion
model of ischemia. Stroke
1987:18:760-764.
32. Fried R. L., Nowak T. S. Opioid
peptide levels in gerbil brain af-
ter transient ischemia: lasting
depletion of hippocampal dyn-
orphin. Stroke 1987:18:765-770.
33. Norris J. W., Hachinski V. C.
High dose steroid treatment in
cerebral infarction. Br Med J
1986:292:21-23.
34. Dyken M. L. Carotid endarter-
ectomy studies: a glimmering of
science. Stroke 1986:17:355-358.
35. Patterson R. H. Can carotid
endarterectomy bejustified? Yes.
Arch Neurol 1987:44:651-652.
36. Jonas S. Can carotid endarter-
ectomy be justified? No. Arch
Neurol 1987:44:652-654.
37. Hachinski V. Carotid endarter-
ectomy. Arch Neurol
1987:44:654.
38. The EC/IC bypass study group.
Failure of extracranial-intracr-
anial arterial bypass to reduce
the risk of ischemic stroke. New
EnglJ Med 1985:313:1191-1200.
39. McDowell F., Flamm E. S. EC/
IC bypass study. Stroke 1986:1-2.
40. Senter H. J., Bittar S. M., Long
E. T. Revascularization of the
extracranial vertebral artery at
any level without cross-clamping.
J Neurosurg 1985:62:334-339.
FARMASÍA HF.,
Brautarholti 2,
S: 25933.
10
LÆKNANEMINN 4Í987-40. árg.